Indegene Ltd Subsidiary to Acquire UK-Based Warn And Co Limited for GBP 3 Million

Indegene Ltd's wholly owned subsidiary, Indegene Ireland Limited, has signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in Warn And Co Limited (Warn or Target Company), a UK-based company providing business transformation consulting solutions for its clients including Life Sciences companies. The transaction does not fall within related party transactions and no promoter/promoter group/group companies have any interest in the entity being acquired. The total purchase consideration amount does not exceed GBP 3 million, subject to net working capital adjustments. Warn has a presence in the UK region and reported revenue of GBP 2.5 million (unaudited) in its last financial year (1 May 2024 to 30 April 2025). The acquisition is expected to complete on or before 17 October 2025.